본문 바로가기
KERD
논문KCI 등재

Effect of Allergic Rhinitis on the Use and Cost of Health Services by Children with Asthma

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: Allergic rhinitis (AR) is common among children with asthma and exacerbates asthma symptoms. To assess the incremental utilization and cost of asthma-related health services due to concomitant AR among asthmatic children. Materials and Methods: Asthma-related claims were extracted from the Korean National Health Insurance (NHI) claims database, which covers 97% of the population. Per-capita utilization and costs of asthma-related services were determined from the societal perspective. Results: Of 319,714 children (1-14 years old) with chronic asthma in 2003, 195,026 had concomitant AR (prevalence 610 per 1,000 asthmatic children). Children with AR had 1.14 times more outpatient visits, 1.30 times more emergency department (ED) visits, and 1.49 times more hospitalizations than children without AR. More children with AR used general hospitals (7.17%) than children without AR (3.23%). The ratios of unit pharmaceutical costs per outpatient visit, ED visit, and admission between children with and without AR were 1.27, 1.20, and 1.14. Total annual expenditure combining direct health care, transportation, and caregivers' costs, were $273 and $217 for children with and without AR, respectively. Conclusion: Health service utilization and costs for asthma were greater for asthmatic children with AR. More frequent ED visits and admissions among asthmatic children with AR suggest poorer control and more frequent exacerbations. Higher unit cost of pharmaceuticals during visits, tendency to receive asthma care from a higher-level facility, and greater risk of ED visit or admission all contributed to the additional economic burden of AR.

Abstract

Purpose: Allergic rhinitis (AR) is common among children with asthma and exacerbates asthma symptoms. To assess the incremental utilization and cost of asthma-related health services due to concomitant AR among asthmatic children. Materials and Methods: Asthma-related claims were extracted from the Korean National Health Insurance (NHI) claims database, which covers 97% of the population. Per-capita utilization and costs of asthma-related services were determined from the societal perspective. Results: Of 319,714 children (1-14 years old) with chronic asthma in 2003, 195,026 had concomitant AR (prevalence 610 per 1,000 asthmatic children). Children with AR had 1.14 times more outpatient visits, 1.30 times more emergency department (ED) visits, and 1.49 times more hospitalizations than children without AR. More children with AR used general hospitals (7.17%) than children without AR (3.23%). The ratios of unit pharmaceutical costs per outpatient visit, ED visit, and admission between children with and without AR were 1.27, 1.20, and 1.14. Total annual expenditure combining direct health care, transportation, and caregivers' costs, were $273 and $217 for children with and without AR, respectively. Conclusion: Health service utilization and costs for asthma were greater for asthmatic children with AR. More frequent ED visits and admissions among asthmatic children with AR suggest poorer control and more frequent exacerbations. Higher unit cost of pharmaceuticals during visits, tendency to receive asthma care from a higher-level facility, and greater risk of ED visit or admission all contributed to the additional economic burden of AR.

참고문헌 (20)

  1. Chung F, "Assessing the burden of respiratory disease in the UK", Respir Med, 96, pp.963~975 (2002)
  2. Strachan D, "Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC)", Pediatr Allergy Immunol, 8, pp.161~176 (1997)
  3. Bousquet J, "Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma", J Allergy Clin Immunol, 108(5), pp.s147~s334 (2001)
  4. Schoenwetter WF, "Economic impact and quality-sof-life burden of allergic rhinitis", Curr Med Res Opin, 20, pp.305~317 (2004)
  5. Blaiss MS, "social, and economic costs of allergic rhinitis", Allergy Asthma Proc, 21, pp.7~13 (2000)
  6. Weiss KB, "6. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact", J Allergy Clin Immunol, 107, pp.3~8 (2001)
  7. Yawn BP, "Allergic rhinitis inRochester, Minnesota residents with asthma: frequency and impact on health care charges", J Allergy Clin Immunol, 103, pp.54~59 (1999)
  8. Grupp-Phelan J, "Health care utilization and cost in children with asthma and selected comorbidities", Asthma, 38, pp.363~373 (2001)
  9. Thomas M, "Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis", Pediatrics, 115, pp.129~134 (2005)
  10. Birnbaum HG, "Using healthcare claims data for outcomes research and pharmacoeconomic analyses", Pharmacoeconomics, 16, pp.1~8 (1999)
  11. Crown WH, "Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns", Value Health, 6, pp.448~456 (2003)
  12. Jung HJ, "Estimating non-covered medical cost", Health Insurance Forum, 1, pp.73~97 (2002)
  13. Yang BM, "Developing criteria for estimating standard costs used in economic evaluation studies for medicines (technical report: Korean)", pp.149~ (2004), Health Insurance Review Agency
  14. Drummond MF, "Chapter 7. Cost-benefit analysis. In: Methods for the economic evaluation of health care programmes", pp.216~ (2005), Oxford University Press
  15. "Age- and gender-specific participation rate to labor market"[URL]
  16. "Statistics for wage structure"[URL]
  17. Korea YWCA, "Personal talk with Korea YWCA administrator", ~ (2004)
  18. Yang BM, "Developing criteria for estimating standard costs used in economic evaluation studies for medicines (technical report: Korean)", Health Insurance Review Agency, pp.152~153 (2004)
  19. Garcia-Garcia ML, "Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: The MOSAIC study", Pediatrics, 116, pp.360~369 (2005)
  20. Kang HY, "Economic burden of smoking in Korea", Tob Control, 12, pp.37~44 (2003)

관련 논문AI추천

소아 알레르기비염의 경제적 부담 평가를 위한 다기관 조사공도연, 권순만, 김경원, 김우경, 민택기, 박용민, 안재억, 양현종, 염혜영, 윤혜선, 전유훈, 편복양대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2012 · 제22권 제2호알레르기비염을 가진 소아의 천식 증상 발생과 관련된 위험 인자권지원, 김효빈, 박유미, 서주희, 이소연, 홍수종대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2020 · 제8권 제4호소아 천식 환자에서 비염과 천식과의 관계: 알레르기비염과 비알레르기비염 비교권은별, 김형윤, 백지현, 신윤호, 윤정원, 지혜미, 최선희, 한만용대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2013 · 제1권 제3호한국 소아의 알레르기비염 역학김수영, 김양호, 김정희, 손병관, 양준모, 오인보, 이근화, 이지호, 이혜숙, 임대현, 정숙영, 홍성철, 황선혜대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2013 · 제1권 제4호소아 알레르기비염과 동반질환; 전신 증상과 천식염혜영, 하은교, 한만용대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2025 · 제13권 제3호A 9-year Trend in the Prevalence of Allergic Disease Based on National Health Insurance Data박윤형, Byoungin Yoo, Hoseob Kim, Kwanjun Park대한예방의학회 · 예방의학회지2015 · 제48권 제6호

이 간행물의 다른 논문 (13건)